Sit Swan has filed 7 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 140000 shares of NovaBay Pharmaceuticals, Inc. ($NBY) on March 31, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | NovaBay Pharmaceuticals, Inc. | $NBY | Sit Swan | Director | A | Restricted Stock Units | 140000 | $0.00 | 140,000.0000 | 126,010,749 | 9999.99% | 0.11% |
| Feb. 5, 2026 | EDGEWELL PERSONAL CARE Co | $EPC | Sit Swan | Not found | A | Restricted Stock Equivalents 2-5-2026 | 7817 | $0.00 | 7,817.0000 | 46,600,000 | 9999.99% | 0.02% |
| Feb. 6, 2025 | EDGEWELL PERSONAL CARE Co | $EPC | Sit Swan | Director | A | Restricted Stock Equivalents 2-6-2025 | 4999 | $0.00 | 4,999.0000 | 48,700,000 | 9999.99% | 0.01% |
| May 28, 2024 | NovaBay Pharmaceuticals, Inc. | $NBY | Sit Swan | Director | A | Restricted Stock Units | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 1, 2024 | EDGEWELL PERSONAL CARE Co | $EPC | Sit Swan | Director | A | Restricted Stock Equivalent 2-1-2024 | 3853 | $0.00 | 3,853.0000 | 51,800,000 | 9999.99% | 0.01% |
| Jan. 31, 2024 | EDGEWELL PERSONAL CARE Co | $EPC | Sit Swan | Director | M | Common Stock | 3318 | $0.00 | 15,499.0000 | 51,800,000 | 27.24% | 0.01% |
| Jan. 31, 2024 | EDGEWELL PERSONAL CARE Co | $EPC | Sit Swan | Director | M | Restricted Stock Equivalent 02/03/2023 | 3318 | $0.00 | 0.0000 | 51,800,000 | 100.00% | 0.01% |